Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Human Gene Therapy

• Publication date

  2009-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.2008.197PMID 19298131PMCID PMC2766423
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Construction and analysis of compact muscle-specific promoters for AAV vectors

  2008cited by this paper
• Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy.

  2008cited by this paper
• Differential effects on kidney and liver growth of a non-viral hGH-expression vector in hypophysectomized mice.

  2007cited by this paper
• A single injection of double-stranded adeno-associated viral vector expressing GH normalizes growth in GH-deficient mice.

  2007influential reference
• Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle.

  2007influential reference
• Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

  2006cited by this paper
• Medical progress: Acromegaly.

  2006cited by this paper
• Effects of recombinant mouse growth hormone treatment on growth and body composition in GHRH knock out mice.

  2005influential reference
• Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

  2005cited by this paper
• A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency.

  2004influential reference
• Can genes transduced by adeno-associated virus vectors elicit or evade an immune response?

  2003cited by this paper
• Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo

  2003cited by this paper
• Clinical effectiveness and cost-effectiveness of growth hormone in children: a systematic review and economic evaluation.

  2002cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment.

  2002cited by this paper
• Muscle-Specific Promoters May Be Necessary for Adeno-Associated Virus-Mediated Gene Transfer in the Treatment of Muscular Dystrophies

  2001cited by this paper
• The somatomedin hypothesis: 2001.

  2001cited by this paper
• Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters

  2001cited by this paper
• Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors.

  2000influential reference
• Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.

  2000cited by this paper
• Long-term regulated expression of growth hormone in mice after intramuscular gene transfer.

  1999cited by this paper
• Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice.

  1999cited by this paper
• Production of Recombinant Adeno‐Associated Viral Vectors

  1999cited by this paper
• Construction and in vivo efficacy of a replication-deficient recombinant adenovirus encoding murine growth hormone.

  1999influential reference
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human.

  1998cited by this paper
• Diagnosis and Treatment of Growth Hormone Deficiency in Children and Adolescents: Towards a Consensus

  1998cited by this paper
• Recent advances in skeletal-muscle-based gene therapy.

  1998cited by this paper
• E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice

  1996influential reference
• Analysis of muscle creatine kinase gene regulatory elements in skeletal and cardiac muscles of transgenic mice

  1996influential reference
• Phenotypic correction of dwarfism by constitutive expression of growth hormone.

  1996influential reference

• Murine toxicology assessment of avgn7.2, a novel gene therapeutic for inclusion body myositis and other muscle wasting diseases

  2025cites this paper
• Codon-optimized human Smad7 gene therapy enhances skeletal muscle mass and function in a murine model of Duchenne muscular dystrophy

  2025cites this paper
• AAV Vector Development, Back to the Future.

  2025cites this paper
• Synthetic Promoters in Gene Therapy: Design Approaches, Features and Applications

  2024cites this paper
• Precision and efficacy of RNA-guided DNA integration in high-expressing muscle loci

  2024cites this paper
• Efficacy and muscle safety assessment of fukutin-related protein gene therapy

  2023cites this paper
• CRISPR-Cas9 homology-independent targeted integration of exons 1–19 restores full-length dystrophin in mice

  2023cites this paper
• Net39 protects muscle nuclei from mechanical stress during the pathogenesis of Emery-Dreifuss muscular dystrophy

  2023cites this paper
• Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing

  2021cites this paper
• Toward the correction of muscular dystrophy by gene editing

  2021cites this paper
• Muscle-Specific Promoters for Gene Therapy

  2021cites this paper
• Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance

  2021cites this paper
• Dynamic Transcriptional Responses to Injury of Regenerative and Non-regenerative Cardiomyocytes Revealed by Single-Nucleus RNA Sequencing.

  2020cites this paper
• Correction of Three Prominent Mutations in Mouse and Human Models of Duchenne Muscular Dystrophy by Single-Cut Genome Editing.

  2020cites this paper
• CRISPR-Mediated Activation of Endogenous Gene Expression in the Postnatal Heart

  2019cites this paper
• CRISPR-Cas9 corrects Duchenne muscular dystrophy exon 44 deletion mutations in mice and human cells

  2019cites this paper
• Development of Novel Micro-dystrophins with Enhanced Functionality

  2019cites this paper
• Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling

  2019cites this paper
• In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse

  2019cites this paper
• Micro-dystrophin Gene Therapy Partially Enhances Exercise Capacity in Older Adult mdx Mice

  2019cites this paper
• CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo

  2018cites this paper
• Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy

  2017cites this paper
• Extensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression

  2017cites this paper
• Progress and prospects of gene therapy clinical trials for the muscular dystrophies.

  2016cites this paper
• Correção fenotípica do nanismo avaliada por diferentes parâmetros de crescimento após administração de DNA plasmidial em modelo animal de deficiência isolada do hormônio do crescimento

  2016cites this paper
• Partial correction of the dwarf phenotype by non-viral transfer of the growth hormone gene in mice: Treatment age is critical.

  2016cites this paper
• A novel homologous model for gene therapy of dwarfism by non-viral transfer of the mouse growth hormone gene into immunocompetent dwarf mice.

  2014cites this paper
• Evaluating Properties of Dystrophin and Delivery Methods of rAAV Gene Therapy for Duchenne Muscular Dystrophy

  2014cites this paper
• Pharmacokinetics and risk evaluation of DNA vaccine against Schistosoma japonicum

  2012cites this paper
• Different ex Vivo and Direct in Vivo DNA Administration Strategies for Growth Hormone Gene Therapy in Dwarf Animals

  2011cites this paper
• Performance Enhancement by Gene Doping

  2010cites this paper